MNX1 and breast cancer: The developed RNAi nanoparticle system enables efficient delivery of MNX1-AS1 siRNA, underscoring the critical therapeutic role of MNX1-AS1 in BC and establishing a novel strategy for BC therapeutics (Fig. 8G).